InvestorsHub Logo
Followers 9
Posts 750
Boards Moderated 0
Alias Born 10/19/2008

Re: None

Monday, 12/14/2015 12:30:50 PM

Monday, December 14, 2015 12:30:50 PM

Post# of 6599
2016 should be interesting. Actual human test results will be coming! I know the primate study needed to reach this stage achieved good results. But nothing compares to being able to actively interview the patient.

I am confident the human results will be positive, but if very strongly positive, wow, look out.

One thing I have not liked about this company is the cash burn and how close it always is to having zero cash. Yet, the thing that has always impressed me is the achieve a good part of what they say they are doing.

They say they are going to make a side business to help fund the research cash burn; they do it. Not only do they do it, but is shows steady growth and product expansion.

They say they will partner with a Japanese pharma and they do for shared product interests.

They say they will work with the leading university on Parkinsons and perform the needed primate studies to allow human studies; and they do it with good results.

They say they will go to Australia to reduce cost and time to market versus the FDA, a successful path for others; and they do it. Not only do they do it, but get the go-ahead from the authorities to proceed in almost record time. What does that mean, it means real human results are here in 2016. Place your bets on what you think the human patients will say. That is the bottom line!

I am not saying to buy, sell or hold, but this company is quite interesting to say the least. At a 14 million market cap, even if things failed eventually, it is hard not to fathom a 200-400 million market cap at some point in all the chaos and activity. Is that a 10+ banger, maybe. Lets hope for all those longs.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ISCO News